Advertisement

Search Results for "Biofortis Company"

14:50 EDT 24th May 2013 | BioPortfolio

Original Source: BioFortis, Inc.

BioFortis is a leading provider of biomedical informatics solutions. Our lead product, Labmatrix(TM), addresses research needs of the post-genomic era within several key application areas including translational research, biobanking, biomarker discovery and clinical research. Labmatrix(TM) is a web-based software application for the management and exploration of clinical, specimen and molecular assay data. With the ability to integrate these data sets in a tightly linked, highly annotated manner, Labmatrix(...

Matching Channels

None

Matching News

BioFortis Inc., Introduces Next Generation Biobanking Software Platform for Biomarker-Based Clinical Research

COLUMBIA, Md., Sept. 19, 2012 /PRNewswire/ -- BioFortis Inc., a leading software company in the clinical and translational research space, today introduced its Next Generation Biobanking sof...

2013 Bio-IT World Best of Show Winners Named

Bio-IT World  | The Bio-IT World Best of Show Awards were announced tonight at the 2013 Bio-IT World Conference and Expo in Boston. New products were recognized from ePharmaSolutions, Bright Computin...

Beyond Fortified Foods: New Clinical Trial Affirms Softgel Sterol/Stanol Supplement Effective for Lowering Cholesterol Levels

As Part of the National Cholesterol Education Program (NCEP) Therapeutic Lifestyle Changes (TLC) diet, Sterol/Stanol Softgels Offer a Convenient Way to Improve Cholesterol Levels NORTHRIDGE...

Innovation Without Borders, at the Heart of Institut Mérieux's Strategy

LYON, France, January 14, 2013 /PRNewswire/ -- Institut Mérieux places innovation at the heart of its development strategy and provides multidisciplinary solutions for the innovative and multifa...

Matching PubMed Articles

Lipid-altering effects of a dietary supplement tablet containing free plant sterols and stanols in men and women with primary hypercholesterolaemia: a randomized, placebo-controlled crossover trial.

This randomized, placebo-controlled, crossover trial assessed the lipid-altering efficacy of a dietary supplement (tablet form) providing 1.8 g/day free (non-esterified) plant sterols and stanols ver...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement